Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | 14.41% |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | -10.40% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -47.39% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | -30.54% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 49.35% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 43.55% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | -2.33% |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.41% |
| Mar 31, 2026 | 9.86% |
| Dec 31, 2025 | 6.93% |
| Sep 30, 2025 | -17.90% |
| Jun 30, 2025 | 226.33% |
| Mar 31, 2025 | -4.04% |
| Dec 31, 2024 | 13.75% |
| Sep 30, 2024 | 12.48% |
| Jun 30, 2024 | -61.48% |
| Mar 31, 2024 | 23.55% |
| Dec 31, 2023 | 90.11% |
| Sep 30, 2023 | -42.24% |
| Jun 30, 2023 | 13.02% |
| Mar 31, 2023 | -53.33% |
| Dec 31, 2022 | 25.64% |
| Sep 30, 2022 | 39.23% |
| Jun 30, 2022 | 77.23% |
| Mar 31, 2022 | -151.17% |
| Dec 31, 2021 | 25.31% |
| Sep 30, 2021 | 10.74% |